Clinical Trials

Showing trials with last updates posted in 2024.

NCT04029688 | TERMINATED | PHASE1/PHASE2
38 participants

A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-20
Start Date:
2020-01-27
Completion:
2024-05-06
Conditions
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Neuroblastoma
  • Solid Tumors
Interventions
  • DRUG
NCT03634540 | ACTIVE_NOT_RECRUITING | PHASE2
118 participants

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-20
Start Date:
2018-09-27
Completion:
2027-02-26
Conditions
  • Renal Cell Carcinoma (RCC)
  • Clear Cell Renal Cell Carcinoma (ccRCC)
  • Kidney Cancer
  • Renal Cancer
  • Renal Cell Carcinoma
  • Renal Cell Cancer Metastatic
  • Renal Cell Carcinoma Recurrent
  • Renal Cell Cancer, Recurrent
  • Kidney
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page